[LONDON] European companies aren't alone in their Brexit pain. Pfizer Inc., the US-based drug behemoth, says its costs for dealing with the upcoming split will reach US$100 million...

PFIZER INC said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 per cent, boosting the prospects of what could be a billion-...

PFIZER Inc said on Tuesday that it was deferring drug price increases for no more than six months after the company's chief executive officer had an extensive conversation with US President...

[NEW YORK] Allergan Plc, which has been looking for ways to counter its stock slump as new threats to its top-selling skin and eye drugs have emerged, is considering options for its women's...

GLAXOSMITHKLINE (GSK) is buying Novartis out of their consumer healthcare joint venture for US$13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets,...

[MIAMI] Twenty years ago, a little blue pill called Viagra unleashed a cultural shift in America, making sex possible again for millions of older men and bringing the once-taboo topic of impotence...

[LONDON] GlaxoSmithKline has quit the race to buy Pfizer's consumer healthcare business, endangering an auction the US drugmaker hoped would bring in as much as US$20 billion...

GLAXOSMITHKLINE plc and Reckitt Benckiser Group plc are the only companies to have submitted non-binding bids for Pfizer Inc's consumer business after rival candidates walked away, according to...